Kames Capital Management’s Allergan Inc AGN Stock Holding History

Kames Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$2.85M	Sell	13,397 -3,088	-19%	-$614K	0.08%	85
2014 Q3	$2.94M	Hold	16,485	–	–	0.09%	92
2014 Q2	$2.79M	Sell	16,485 -1,719	-9%	-$268K	0.09%	88
2014 Q1	$2.26M	Hold	18,204	–	–	0.07%	97
2013 Q4	$2.02M	Sell	18,204 -220,978	-92%	-$21.1M	0.07%	108
2013 Q3	$21.6M	Sell	239,182 -13,365	-5%	-$1.2M	0.67%	50
2013 Q2	$21.3M	Buy	+252,547	New	+$26.2M	0.75%	53

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Kames Capital Management's AGN Position: Q4 2014 in Review

Kames Capital Management reduced its Allergan Inc (AGN) stake by 19% in Q4 2014, selling an estimated $614K and leaving 13,397 shares worth $2.85M. The position accounts for 0.08% of the portfolio, ranked #85.

Kames Capital Management first reported a position in AGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $21.6M in Q3 2013. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

Kames Capital Management held 13,397 shares of Allergan Inc worth $2.85M as of Q4 2014.
Kames Capital Management sold 3,088 Allergan Inc shares in Q4 2014, an estimated $614K.
Allergan Inc made up 0.08% of Kames Capital Management's portfolio in Q4 2014, its #85 holding.
Kames Capital Management first reported a position in Allergan Inc in Q2 2013 and has held it in 7 quarters since.
Kames Capital Management's Allergan Inc position peaked at $21.6M in Q3 2013.
819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.